Bone and idiopathic calcium nephrolithiasis

Italian Journal of Mineral and Electrolyte Metabolism

Volumn 10, Issue 2, 1996, Pages 83-94

  Ghazali, A ^a   Hardy Yverneau, P ^a   Bataille, P ^a   Achard, J M ^a   Marie, A ^a   Brazier, M ^a   Sebert, J L ^a   Prin, L ^a   Fournier, A ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

bone mineral density; bone remodelling markers; calciotropic hormones; calcium nephrolithiasis; local factors; osteopenia

Indexed keywords

PARATHYROID HORMONE; PROLINE;

BONE DENSITY; CALCIUM STONE; DIET; HISTOCHEMISTRY; HUMAN; HYPERCALCIURIA; NEPHROLITHIASIS; OSTEOLYSIS; REVIEW; STONE FORMATION;

EID: 0030497897     PISSN: 11211709     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Fournier A, Ghazali A, Bataille P, Cohen Solal M, Marie A, Brazier M et al. Bone involvement in idiopathic calcium stone former. In: Kidney Stones: Medical and surgical Management. Coe FL, Favus MJ, Pake CYC, Parks JH, Pemininger GM, editors. Philadelphia: Lippincott-Raven Publishers, 196;921-40.
2. Lemann J Jr. Pathogenesis of idiopathic hypercalciuria and nephrolithiasis. In: Coe FL, Favus MJ, editors. Disorders of bone and mineral metabolism. New York: Raven Press, 1922;685-706.
3. Breslau NA. Pathogenesis and management of hypercalciuric nephrolithiasis. Miner Electrolyte Metab 1994;20:328-39.
4. Pak CYC, Britton F, Peterson R. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med 1980;69:19-30.
5. Xiao Quiang L, Tenibe V, Horowitz GM, Bushinsky DA, Favus MJ. Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal hyperabsorption of calcium. J Clin Invest 1993;91:661-7.
6. 3 induced bone resorption in calvariae from genetic hypercalciuric rats. J Bone Miner Res 1992;7:S166.
7. Zerwekh JE, Yu XP, Breslau NA, Manolagas S, Pak CYC. Vitamin D receptor quantitation in human blood mononuclear cells in health and disease. Mal Cell Endocrinol 1993;96:1-6.
8. Burckhardt P, Jaeger P. Secondary hyperparathyrodism in idiopathic renal hypercalciuria: fact or theory? J Clin Endocrinol Metab 1981;53:550-5.
9. Bataille P, Achard JM, Fournier A. Diet vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 1991;39:1193-205.
10. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995;98:50-9.
11. Alhava EM, Juuti M, Karjalainen P. Bone mineral density in patients with urolithiasis. Scand J Urol Nephrol 1976;10:154-6.
12. Barkin J, Wilson DR, Manuel MA, Arnold B, Murray T, Harrison J. Bone mineral content in idiopathic calcium nephrolithiasis. Mineral Electrolyte Metab 1985;11:19-24.
13. Casez JP, Hug C, Ackerman D, Zingg E, Jaeger PH. Bone mineral density of lumbar spine, femoral neck and distal tibial in patients with calcium nephrolithiasis. Urol Res 1990;18:66 (abstract).
14. Fuss M, Papersack T, Van Geel J. Involvement of low-calcium diet in the reduced mineral content in idiopathic renal stone formers. Calcif Tissue Int 1990;46:9-13.
15. Casez JP, Hug C, Hess B, Lippuner K, Ackermann D, Jaeger PH. The myth of low bone mass in idiopathic calcium renal stone formers. Kidney Int 1993;44:264(abstract).
16. Velentzas C, Oreopoulos DG, Meema S. Dietary calcium restriction may be good from patient's stone but not for their bones. In: Smith J, Robertson S, Finlayson C, editors. Urolithiasis clinical and basic research. New York: Plenum Press, 1981;847-54.
17. Fuss M, Gillet C, Simon J, Vandewalle JC, Schoutens A, Bergmann P. Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol 1983;9:32-4.
18. th international symposium on urolithiasis. New York: Plenum Press, 1988:391-7.
19. Pacifici R, Rothstein M, Pifas L. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1990;71:138-45.
20. Pietschmann F, Breslau NA, Pak CYC. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 1992;7:1383-8.
21. Hess B, Casez JP, Takkinen D, Ackerman D, Jaeger P. Relative hypoparathyroidism and calcitriol up-regulation in hypercalciuric calcium renal stone formers. Impact of nutrition. Am J Nephrol 1993;13:18-26.
22. Alonzo E, Durrego P, Blassini A. Role of cytokines and type of hypercalciuria in the bone mineral loss of idiopathic hypercalciuria. XIIth International Congress of Nephrology. Jerusalem, Israel; 1993;620(abstract).
23. Jaeger P, Lippuner K, Casez JP. Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 1994;9:1525-32.
24. Daragon A, Dhib M, Morin JP, Godin M, Fillastre JP. Hypercalciurie idiopathique et densité osseuse. Rev Rhum Mal Osteoartic 1992;59:35-8.
25. Da Silva AMM, Dos Reis LM, Pereira RC. Bone histomorphometric and bone mineral content in idiopathic hypercalciuria patients. XIIth International Congress of Nephrology. Jerusalem, Israel 1993:620 (Abstract).
26. Borghi L, Meschi T, Guerra A. Vertebral mineral contnet in diet-dependent and diet-independent hypercalciuria. J Urol 1991; 146:1334-8.
27. Audran M, Bataille P, Seben JL. La densité osseuse dans l'hypercalciurie idiopatique chez l'homme. Rev Rhum Mal Osteoartic 1991; 58:747-50.
28. Ghazali A, Fuentes V, Desaint C, Bataille P, Westeel A, Brozier M, Prin Land Fourvier A. Low bone mineral density and peripheral blood monocyte activation in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 1997;28 (in press).
29. Lawoyin S, Sismilich S, Browne R, Pak CYC. Bone mineral content in patietns with primary hyperparathyroidism, osteoporosis, and calcium urolithiasis. Metabolism 1979;28:1250-4.
30. Lindergard B, Colleen S, Mansson W, Rademark C, Rogland B. Calcium loading test and bone disease in patient with urolithiasis. Proceed EDTA 1983;20:460-5.
31. Malvasi L, Sartori L, Giannimi S. Mineral metabolism and bone mineral content in calcium nephrolithiasis with or without hyperparathyroidism. Urol Res 1988;16:190(abstract).
32. Heilberg IP, Martini LA, Szejnfeld VL. Bone disease in calcium stone forming patients. Clin Nephrol 1994;42(3):175-82.
33. Bordier Ph, Rychewart Ph DA, Gueris J, Rasmussen H. On the pathogenesis of so-called idiopathic hypercalciuria. Am J Med 1977;63:398-409.
34. De Vernejoul MC, Hioco D, Villaumey J, Chanzy MO, Voisin MC, Canalia AM. Etude histomorphométrique osseuse au cours de l'hypercalciurie idiopatique. Rev Rhum Mal Osteoartic 1981;48:389-95.
35. Malluche HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massery SG. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 1980;50:654-8.
36. Steiniche T, Morsekilde L, Christensen MS, Melsen F. A histomorphometric determination of iliac bone remodelling in patients with recurrent renal stone formation and idiopathic hypercalciuria. Acta Pathol Microbiol Immunol Scand 1989;97: 309-16.
37. Bataille P, Marie A, Steiniche I, Cohen Solal ME, Brazier M, Sebert JL, Fournier A. Decreased bone formation in idiopathic hypercalciuric calcium stone formers explains reduced bone density. Proceeding of the XIII International Congress of Nephrology. Madrid, June 1995 (abstract).
38. Thomas J, Roujean J, Aboulker P. Les lésions osseuses dans la lithiase rénale. Leur étude par examen histologique d'un fragment costal. Presse Med 1962;70:2437-40.
39. Bataille P, Charansol G, Gregoire I. Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones. J Urol 1983;130:218-23.
40. 3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 1982;72:25-32.
41. Coe FL, Bushinsky DA. Pathophysiology of hypercalciuria. Am J Physiol 1984;247:F1-F13.
42. Lieberman UA, Sperling O, Atsmon A, Frank M, Modan M, De Vries A. Metabolic and calcium kinetic studies in idiopathic hypercalciuria. J Clin Invest 1968;47:2580-9.
43. Messa P, Mioni G, Montanaro D. About a primitive osseous origin of the so-called renal hypercalciuria. Contr Nephrol 1987; 58:106-10.
44. Curhan GC, Willet WC, Rimm EB, Stamper MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8.
45. Goldfarb S. Dietary factors in the pathogenesis and prophylaxis of calcium nephrolithiasis. Kidney Int 1988;34:544-55.
46. Wachman A, Bernstein DS. Diet and osteoporosis. Lancet 1968;i:958-9.
47. Breslau NA, Brinkley L, Hill KD, Pak CYC. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 1988;66:140-6.
48. Lemann J Jr, Litzow JR, Lennon EJ. The effect of chronic acid loads in normal man: Further evidence for the partecipation of bone mineral in the defence against chronic metabolic acidosis. J Clin Invest 1966;45:1608-14.
49. Lemann J. Urinary calcium excretion and net acid excretion: effects of dietory protein, carbohydrate and calories. In: Schille PO, Smith LH, Robertson WG, Finlayson B, editors. Urolithiasis and related clinical research. New York: Plenum Press, 1985;53-60.
50. Huffer WE. Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone and other substances. Lab Inv 1959;59:418-22.
51. Adams ND, Gray RW, Lemann J, Cheung HS. Effects of calcitriol administration on calcium metabolism in healthy men. Kidney Int 1982;21:90-7.
52. 2 vitamin D concentrations in healthy man. Kidney Int 1983;24:555-66.
53. Shen FH, Baylink DJ, Nielsen RL, Sherrard DJ, Ivey JL, Haussler MR. Increased serum 1,25 dihydroxyvitamin D in idiopathic hypercalciuria. J Lab Clin Med 1977;90:955-62.
54. 3 in patients with absorptive hypercalciuria. J Clin Endocrinol Metab 1985;61:490-5.
55. 3 in calcium stone formers with idiopathic hypercalciuria. In: Linari A, Marangella G, editors. Pathogenesis and treatment of nephrolithiasis. Contributions to Nephrology. Basel: Karger 1986;58:50-3.
56. Filipponi P, Mannarelli C, Pacifici R. Evidence for a prostaglandin mediated bone resorptive mechanism in subjects with fasting hypercalciuria. Calcif Tissue Int 1988;43:61-6.
57. Wark JD, Larkins RG, Eisman JA, Martin TJ. Prostaglandins and 25 hydroxy vitamin D a-hydroxylase. In: Norman AN, editor. Vitamin D, basic research and its clinical application. Berlin-New York: Walter de Gruyter, 1977:563-6.
58. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJP, Mundy GR. Effects of interleukin 1 on bone turnover in normal mice. Endocrinology 1989;125:1142-50.
59. Pacifici R, Rifers L, Teitlbaum S, Slatopolsky E, Miller R. Spontaneous release of interleukin 1 from human blood monocytes reflects bone resorption in idiopathic osteoporosis. Proc Natl Acad Sci USA 1987;84:4616-20.
60. Constantini F, Yamoto M, Markatos A, Cortese R, Rodan GA, Poli V. Mice with IL-6 gene knock-out do not lose calcellous bone after ovariectomy. J Bone Miner Res 1993;8(Abstract): S130.
61. Jilka RL, Hangoc G, Girasole G. Increased osteoclast development after estrogen loss: mediation by IL-6. Science 1992;257: 88-91.
62. Weisinger JR, Alonzo E, Bellorin-Font E. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 1996;49:244-50.
63. Chaterwood BD, Fubin J. The vitamin D response element mediates the inhibitory effect of TNF-α on osteocalcin gene transcription. J Bone Miner Res 1993;8:163.
64. Bertolini DR, Nedurin GC, Bringman TS, Smith DD, Munday GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 1986;319:516-8.